Network Pharmacology-based analysis of Resinacein S against non-alcoholic fatty liver disease by modulating lipid metabolism

ABSTRACT: In order to investigate the hub regulated genes of Resinacein S against NAFLD in human liver cells, we treated the normal human hepatic cell line L02 with Resinacein S and detected the gene expression profiles by RNA-Seq.

ORGANISM(S): Homo sapiens

PROVIDER: GSE223990 | GEO | 2023/01/29

REPOSITORIES: GEO